From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome

This publication has 25 references indexed in Scilit:

• Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
  British Journal of Cancer, 2001
• Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial
  Radiotherapy and Oncology, 2001
• UPDATED DATA FOR CHART IN NSCLC: FURTHER ANALYSES
  Radiotherapy and Oncology, 2000
• Quantitative clinical radiobiology of early and late lung reactions
  International Journal of Radiation Biology, 2000
• Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
  Radiotherapy and Oncology, 1999
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
  Lung Cancer, 1999
• Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
  The Lancet, 1997
• Quantifying the position and steepness of radiation dose-response curves
  International Journal of Radiation Biology, 1997
• Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study
  Radiotherapy and Oncology, 1989